Abstract
Atopic diseases are characterized by Th2 and IgE responses to common environmental and food antigens. In vivo, IgE production depends on interactions between allergen-specific B lymphocytes and Th2 lymphocytes. IgE levels are extremely low in normal individuals, suggesting that IgE production is under strong regulation. One of the reasons behind the lack of atopy in healthy individuals is the activity of regulatory T cells, which prevent naïve T helper cell precursors from acquiring a differentiated Th2 phenotype. In addition to naturally occurring regulatory T cells, atopy can be prevented by allergen-specific tolerant/regulatory cells induced through mucosal stimulation, and by mechanisms that directly suppress Iε sterile transcript production on activated B lymphocytes. This article reviews the recent progress on thymic-derived as well as peripherally induced regulatory T cells as they relate to atopy. The latter discussion also includes regulatory T cells that arise through immunotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 295-310 |
| Number of pages | 16 |
| Journal | Springer Seminars in Immunopathology |
| Volume | 25 |
| Issue number | 3-4 |
| DOIs | |
| State | Published - Feb 2004 |
| Externally published | Yes |
Keywords
- Atopy
- CD4CD25 T cells
- Class switching
- Immunoglobulin E
- Th2 differentiation